6 completed, 2 terminated, 2 withdrawn, 1 recruiting. 11 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 6, Terminated 2, Withdrawn 2, Recruiting 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow idebenone: new trials by email Literature Review of idebenone trials Research Report on idebenone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Idebenone for the Preventive Treatment of Migraine Placebo, 90mg Idebenone, 270mg Idebenone - Migraine Disorders, Headache Disorders | Phase 3 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 180 | 2021-12-08 | 2025-05-15 |
| A Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson Disease Idebenone, Placebo oral tablet - REM Sleep Behavior Disorder, Parkinson Disease | Phase 2 / Phase 3 | Withdrawn | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-01-01 | 2025-01-07 | |
| Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E) idebenone 150 mg film-coated tablets - Duchenne Muscular Dystrophy | Phase 3 | Terminated | Santhera Pharmaceuticals | 161 | 2018-07-04 | 2021-12-03 |
| A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids Idebenone 150 mg film-coated tablets, placebo - Duchenne Muscular Dystrophy (DMD) | Phase 3 | Terminated | Santhera Pharmaceuticals | 255 | 2016-09-01 | 2021-12-03 |
| Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI) Idebenone, Placebo - Friedreich's Ataxia | Phase 3 | Completed | Santhera Pharmaceuticals | 29 | 2011-04-01 | 2016-03-09 |
| Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD) Placebo, Idebenone - Muscular Dystrophy, Duchenne, Ambulatory Care | Phase 3 | Completed | Santhera Pharmaceuticals | 65 | 2009-07-01 | 2015-10-19 |
| Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients Idebenone - Friedreich's Ataxia | Phase 3 | Completed | Santhera Pharmaceuticals | 68 | 2008-07-01 | 2023-07-11 |
| Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Idebenone, Placebo - Friedreich's Ataxia | Phase 3 | Completed | Santhera Pharmaceuticals | 70 | 2007-12-01 | 2023-07-11 |
| Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension) idebenone - Freidreich's Ataxia | Phase 3 | Completed | Santhera Pharmaceuticals | 200 | 2007-06-01 | 2018-03-05 |
| A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients idebenone, Placebo - Friedreich's Ataxia | Phase 3 | Completed | Santhera Pharmaceuticals | 232 | 2006-04-01 | 2016-06-27 |
| Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON) Idebenone, Placebo - Leber's Hereditary Optic Neuropathy | Phase 3 | Withdrawn | Santhera Pharmaceuticals | 2014-08-22 |
Friedreich Ataxia (4) · Muscular Dystrophy, Duchenne (3) · Headache Disorders (1) · Migraine Disorders (1) · Mitochondrial Diseases (1) · Optic Atrophy, Hereditary, Leber (1) · Parkinson Disease (1) · REM Sleep Behavior Disorder (1) · Respiratory Aspiration (1)
Santhera Pharmaceuticals (9) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2)
Austria (6) · Germany (6) · Belgium (5) · France (5) · Netherlands (5) · United States (5) · United Kingdom (4) · Italy (3) · Spain (3) · Switzerland (3) · China (2) · Sweden (2) · Bulgaria (1) · Hungary (1) · Ireland (1)
David Lynch, MD (2) · Nick Wood, Professor (2) · Susan Perlman, MD (2) · Ana Camacho Salas, MD (1) · Ass. Prof. Jan Verschuuren, MD, PhD (1) · Baorong Zhang, MD (1) · Barry Byrne, MD (1) · Bryan W. Burnette, MD (1) · Craig McDonald, MD (1) · Dr. Pierre-Yves Jeannet, Médecin Associé, MER (1) · Dr. Ulrike Schara, MD, PhD (1) · Ericka Simpson, MD (1) · Gihan Tennekoon, MD (1) · Janbernd Kirschner, MD (1)
PMID 21779958, PMID 11972582, PMID 20065258, PMID 20697044, PMID 21392622, PMID 21586650, PMID 21788663, PMID 25907158, PMID 25916335, PMID 28132202, PMID 28189481, PMID 29298622